| Patent application number | Description | Published |
|---|
| 20080227784 | N-(3,4-disubstituted phenyl) salicylamide derivatives - A compound represented by the following formula (I) or a salt thereof: | 09-18-2008 |
| 20080234233 | MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES - A medicament for preventive and/or therapeutic treatment of neurodegenerative diseases such as Alzheimer's disease or the like which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: | 09-25-2008 |
| 20080249071 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR - A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient: | 10-09-2008 |
| 20080249175 | N-Phenyloxamide derivatives - A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): | 10-09-2008 |
| 20080275116 | Carboxilic acid derivatives - A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): | 11-06-2008 |
| 20080281864 | Method of Displaying Molecule Function Network - A graphical user interface that generates a molecule function network with an arbitrary range according to the designation by a user and displays the said molecule function network graphically; a graphical user interface with a molecule network window which displays a molecule network included in the molecule function network and an information window which displays one or more information items selected form a group comprising molecules, molecule pairs and bio-events included in the said molecule function network, which is characterized by that items in the molecule network window and in the information window related with each other are operated interlinked with each other. A molecule function network with information on bio-events including pathological events can be processed and displayed flexibly using a computer. | 11-13-2008 |
| 20080311074 | Inhibitors against activation of NF-kappaB - A method of inhibiting NF-κB activation in a mammal including a human, which comprises the step of administering an effective dose of a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: | 12-18-2008 |
| 20080318956 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR - A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient: | 12-25-2008 |
| 20090192122 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR -
A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient:
| 07-30-2009 |
| 20090215899 | N-Phenyloxamide derivatives - A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): | 08-27-2009 |
| 20090239868 | INHIBITOR OF PAI-1 PRODUCTION - The compound represented by the following general formula (I) has an inhibitory activity on PAI-1 production; | 09-24-2009 |
| 20090312315 | PAI-1 INHIBITOR - The compound represented by the following formula (I) and the like have PAI-1 inhibition activity; | 12-17-2009 |
| 20100113448 | OXAZOLIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 - Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor. | 05-06-2010 |
| 20100113770 | O-SUBSTITUTED HYDROXYARYL DERIVATIVES - A medicament having inhibitory activity against NF-κB activation which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: | 05-06-2010 |
| 20100234363 | HETEROCYCLIC DERIVATIVE HAVING INHIBITORY ACTIVITY ON TYPE-I 11 DATA-HYDROXYSTEROID DEHYDROGENASE - Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor. | 09-16-2010 |
| 20100274051 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR - A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or α pharmacologically acceptable salt as an active ingredient: | 10-28-2010 |
